MoneyWorks4Me

Alembic Pharma planning to raise capital via NCDs

07 Jun 2019 Evaluate

Alembic Pharmaceuticals is planning to raise capital through way of issuance of Non-Convertible Debentures (NCDs) on Private Placement Basis. The Board of Directors of the Company at its meeting to be held on June 12, 2019 to consider the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..